How tiny enzyme differences steer cannabis cannabinoid production

X-ray crystal structures of the cannabinoid synthases CBCAS, CBDAS and THCAS.

Current research in structural biology • • Highly Relevant
🤖

AI Summary

This structural biology study examines the three major cannabinoid-producing enzymes: cannabichromenic acid synthase (CBCAS), cannabidiolic acid synthase (CBDAS), and tetrahydrocannabinolic acid synthase (THCAS). These enzymes use the common precursor cannabigerolic acid (CBGA) to produce the acidic forms of CBC, CBD, and THC. The researchers determined X-ray crystal structures for CBCAS and CBDAS, along with a higher-resolution structure of THCAS, with each enzyme bound to the coenzyme FAD.

The structures show that small differences around and beyond the enzymes’ active sites may explain why closely related proteins produce different cannabinoids. The findings do not measure effects in cannabis users or demonstrate improved production, but they provide a structural blueprint for engineering these enzymes. In the longer term, this could support biological or industrial production of specific cannabinoids and the development of enzyme pathways with altered selectivity.

💡 Key Findings

1
The study presents structures for CBCAS and CBDAS, plus a higher-resolution structure of THCAS, each bound to the coenzyme FAD.
High
85%
2
Differences in active-site amino acids and more distant regions may help explain why these related enzymes produce different cannabinoids from the shared precursor CBGA.
High
80%
3
The structures provide a platform for rational enzyme engineering aimed at changing or improving cannabinoid production selectivity.
High
80%
4
The findings concern cannabinoid biosynthesis rather than the medical or behavioral effects of THC, CBD, or other cannabis compounds in people.
High
95%

📄 Original Abstract

The enzymes Cannabichromenic Acid Synthase (CBCAS), Cannabidiolic Acid Synthase (CBDAS) and Tetrahydrocannabinolic Acid Synthase (THCAS) are together the major cannabinoid synthase enzymes responsible for the biosynthesis of their respective metabolites from a common precursor Cannabigerolic Acid (CBGA). As the catalysts responsible for generating biological molecules of significant pharmaceutical value, there has been considerable interest in the enzymes with respect to heterologous production, mechanism, and incorporation into synthetic biology pathways for the facile industrial production of these molecules. The enzymes share high degrees of homology, and therefore their distinct specificities are governed by very subtle differences in sequence and therefore structure, although, until now, only a structure for THCAS has been reported. In this report, we present structures of CBCAS, CBDAS and a structure of THCAS at a higher resolution than the known structure, each in complex with their flavin coenzyme FAD. The structures reveal active site differences that may be responsible for the complementary activities observed, in terms of both first-shell amino acid substitutions, but also in more remote residues that influence active site topology through referred effects, or that have effects on substrate access. The structures provide a useful and informative platform for the rational engineering of improved or altered chemoselectivity in these enzymes.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.